News & Updates

Show Multimedia Only

Managing advanced colorectal cancer with robotic surgery

19 Mar 2025 by

In colorectal cancer, the traditional method for removing the tumour is open surgery. However, the surgical treatment landscape has evolved over the years and transitioned to embrace the utilization of minimally invasive approaches such as laparoscopic or keyhole surgery and the use of robotics.

Managing advanced colorectal cancer with robotic surgery

19 Mar 2025

Probiotics help relieve chemo-induced diarrhoea

18 Mar 2025

The use of probiotics leads to a significant reduction in chemotherapy-related diarrhoea, suggesting its potential as supportive care agent in oncology, according to a study.

Probiotics help relieve chemo-induced diarrhoea

18 Mar 2025

Tislelizumab plus nab-paclitaxel shows therapeutic potential against bladder cancer

18 Mar 2025

Treatment with the combination of the immune checkpoint inhibitor tislelizumab plus low-dose nab-paclitaxel exerts promising antitumour activity in patients with very high risk non–muscle-invasive bladder cancer who are ineligible for or decline radical cystectomy, according to the results of the phase II TRUCE-02 trial.

Tislelizumab plus nab-paclitaxel shows therapeutic potential against bladder cancer

18 Mar 2025

Family history of CRC ups risk of adenoma, neoplasia

17 Mar 2025 by

Individuals with a family history of colorectal cancer (CRC) are at greater risk of developing adenoma, nonadvanced adenoma (NAA), advanced adenoma (AA), and advanced neoplasia (AN), reveals a study.

Family history of CRC ups risk of adenoma, neoplasia

17 Mar 2025

TXA use in radical cystectomy reduces bleeding, need for blood transfusion

14 Mar 2025

Using tranexamic acid (TXA) appears to lessen blood loss and the need for perioperative blood transfusion (PBT) without increasing the risk of venous thromboembolism (VTE) in patients with bladder cancer undergoing radical cystectomy, reports a study.

TXA use in radical cystectomy reduces bleeding, need for blood transfusion

14 Mar 2025

Original New Drug Application Approvals by US FDA (16-28 February 2025)

14 Mar 2025

New drug applications approved by US FDA as of 16-28 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-28 February 2025)

14 Mar 2025

Study reveals liver- and tumour-specific indicators against repeat TACE in HCC patients

14 Mar 2025 by

Repeat transarterial chemoembolization (TACE) is not recommended for patients with hepatocellular carcinoma (HCC) who have persistent liver function deterioration after initial TACE, particularly if they have suboptimal baseline liver function or excessive tumour burden, according to researchers from the Chinese University of Hong Kong (CUHK).

Study reveals liver- and tumour-specific indicators against repeat TACE in HCC patients

14 Mar 2025

Young adults unaware of male HPV infection, vaccine benefits

13 Mar 2025 by

Awareness about human papillomavirus (HPV) infection in males and the benefits of vaccination on both genders is low among young adults, reveals a Singapore study.

Young adults unaware of male HPV infection, vaccine benefits

13 Mar 2025

Preop smoking ups postop complications for cancer surgery patients

12 Mar 2025 by

Smoking within 4 weeks of cancer surgery translates to a higher number of complications after the procedure.

Preop smoking ups postop complications for cancer surgery patients

12 Mar 2025

NIPS regimen improves OS in gastric cancer with peritoneal metastasis

12 Mar 2025 by

Among patients with gastric cancer and peritoneal metastasis, treatment with neoadjuvant intraperitoneal–systemic (NIPS) regimen, which consists of intraperitoneal (IP) and intravenous (IV) paclitaxel plus S-1, significantly improved overall survival (OS) compared with IV paclitaxel plus S-1 only (PS regimen), according to the DRAGON-01 trial presented at ASCO GI 2025.

NIPS regimen improves OS in gastric cancer with peritoneal metastasis

12 Mar 2025

News & Updates

Filter by Specialty:

Specialty:

Managing advanced colorectal cancer with robotic surgery

Managing advanced colorectal cancer with robotic surgery

Probiotics help relieve chemo-induced diarrhoea

Probiotics help relieve chemo-induced diarrhoea

Tislelizumab plus nab-paclitaxel shows therapeutic potential against bladder cancer

Tislelizumab plus nab-paclitaxel shows therapeutic potential against bladder cancer

Family history of CRC ups risk of adenoma, neoplasia

Family history of CRC ups risk of adenoma, neoplasia

TXA use in radical cystectomy reduces bleeding, need for blood transfusion

TXA use in radical cystectomy reduces bleeding, need for blood transfusion

Original New Drug Application Approvals by US FDA (16-28 February 2025)

Original New Drug Application Approvals by US FDA (16-28 February 2025)

Study reveals liver- and tumour-specific indicators against repeat TACE in HCC patients

Study reveals liver- and tumour-specific indicators against repeat TACE in HCC patients

Young adults unaware of male HPV infection, vaccine benefits

Young adults unaware of male HPV infection, vaccine benefits

Preop smoking ups postop complications for cancer surgery patients

Preop smoking ups postop complications for cancer surgery patients

NIPS regimen improves OS in gastric cancer with peritoneal metastasis

NIPS regimen improves OS in gastric cancer with peritoneal metastasis